{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:03:56Z","timestamp":1761102236723},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","valueinhealthjournal.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jval.2016.09.2395","type":"journal-article","created":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T04:18:52Z","timestamp":1478319532000},"page":"126-131","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Influence of Genotype Information on Psychiatrists\u2019 Treatment Recommendations: More Experienced Clinicians Know Better What to Ignore"],"prefix":"10.1016","volume":"20","author":[{"given":"Alan J.","family":"McMichael","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Boeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan J.","family":"Rolison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Kane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis A.","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ric","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Kee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2016.09.2395_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1586\/erp.13.29","article-title":"Stratified medicine: a call for action","volume":"13","author":"Jacob","year":"2013","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.jval.2016.09.2395_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrd2251","article-title":"Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers","volume":"6","author":"Trusheim","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jval.2016.09.2395_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.biopsych.2009.08.030","article-title":"Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches","volume":"67","author":"Ikeda","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jval.2016.09.2395_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.drudis.2009.12.004","article-title":"Use of biomarkers in the discovery of novel anti-schizophrenia drugs","volume":"15","author":"Mikkelsen","year":"2010","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jval.2016.09.2395_bib5","doi-asserted-by":"crossref","first-page":"e2161","DOI":"10.1136\/bmj.e2161","article-title":"Personalised medicine: not just in our genes","volume":"344","author":"Kitsios","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2016.09.2395_bib6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00415-009-0084-2","article-title":"Multiple sclerosis patients\u2019 benefit-risk preferences: serious adverse event risks versus treatment efficacy","volume":"256","author":"Johnson","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.jval.2016.09.2395_bib7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.18553\/jmcp.2010.16.8.616","article-title":"Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn\u2019s disease management","volume":"16","author":"Johnson","year":"2010","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.jval.2016.09.2395_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2500\/aap.2009.30.3205","article-title":"Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta 2-agonist maintenance medications","volume":"30","author":"Hauber","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jval.2016.09.2395_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.lungcan.2012.01.016","article-title":"Patients\u2019 preferences for treatment outcomes for advanced non-small cell lung cancer: a conjoint analysis","volume":"77","author":"Bridges","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jval.2016.09.2395_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hec.1697","article-title":"Discrete choice experiments in health economics: a review of the literature","volume":"21","author":"De Bekker-Grob","year":"2012","journal-title":"Health Econ"},{"key":"10.1016\/j.jval.2016.09.2395_bib11","unstructured":"Food and Drug Administration. Patient preference information\u2014submission, review in PMAs, HDE applications, and de novo requests, and inclusion in device labeling draft guidance for industry, Food and Drug Administration staff. 2015. Available from: http:\/\/www.fda.gov\/ucm\/groups\/fdagov-public\/@fdagov-meddev-gen\/documents\/document\/ucm446680.pdf [Accessed May 6, 2016]."},{"key":"10.1016\/j.jval.2016.09.2395_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-psych-120709-145346","article-title":"Heuristic decision making","volume":"62","author":"Gigerenzer","year":"2011","journal-title":"Annu Rev Psychol"},{"key":"10.1016\/j.jval.2016.09.2395_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10640-008-9198-8","article-title":"Incorporating discontinuous preferences into the analysis of discrete choice experiments","volume":"41","author":"Campbell","year":"2008","journal-title":"Environ Resour Econ"},{"key":"10.1016\/j.jval.2016.09.2395_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jhealeco.2014.06.012","article-title":"Elimination and selection by aspects in health choice experiments: prioritising health service innovations","volume":"38","author":"Erdem","year":"2014","journal-title":"J Health Econ"},{"key":"10.1016\/j.jval.2016.09.2395_bib15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s11116-012-9447-0","article-title":"Accounting for attribute non-attendance and common-metric aggregation in a probabilistic decision process mixed multinomial logit model: a warning on potential confounding","volume":"40","author":"Hensher","year":"2012","journal-title":"Transportation (Amst)"},{"key":"10.1016\/j.jval.2016.09.2395_bib16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.tre.2008.12.001","article-title":"Simplifying choice through attribute preservation or non-attendance: implications for willingness to pay","volume":"45E.4","author":"Hensher","year":"2009","journal-title":"Transp Res E Logistics Transp Rev"},{"key":"10.1016\/j.jval.2016.09.2395_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11116-004-7613-8","article-title":"The implications on willingness to pay of respondents ignoring specific attributes","volume":"32","author":"Hensher","year":"2005","journal-title":"Transportation (Amst)"},{"key":"10.1016\/j.jval.2016.09.2395_bib18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.reseneeco.2012.04.001","article-title":"Cost thresholds, cut-offs and sensitivities in stated choice analysis: identification and implications","volume":"34","author":"Campbell","year":"2012","journal-title":"Resour Energy Econ"},{"key":"10.1016\/j.jval.2016.09.2395_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ajae\/aas073","article-title":"Inferred and stated attribute non-attendance in food choice experiments","volume":"95","author":"Scarpa","year":"2013","journal-title":"Am J Agric Econ"},{"key":"10.1016\/j.jval.2016.09.2395_bib20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/agec.12036","article-title":"Sparkling wine choice from supermarket shelves: the impact of certification of origin and production practices","volume":"44","author":"Thiene","year":"2013","journal-title":"Agric Econ"},{"key":"10.1016\/j.jval.2016.09.2395_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/erae\/jbp012","article-title":"Modelling attribute non-attendance in choice experiments for rural landscape valuation","volume":"36","author":"Scarpa","year":"2009","journal-title":"Eur Rev Agric Econ"},{"key":"10.1016\/j.jval.2016.09.2395_bib22","unstructured":"Collins A. Attribute nonattendance in discrete choice models: measurement of bias, and a model for the inference of both nonattendance and taste heterogeneity. 2012. Available from: http:\/\/ses.library.usyd.edu.au\/handle\/2123\/8966. [Accessed November 10, 2015]."},{"key":"10.1016\/j.jval.2016.09.2395_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jebo.2013.09.009","article-title":"Inferred vs. stated attribute non-attendance in choice experiments: a study of doctors\u2019 prescription behaviour","volume":"96","author":"Hole","year":"2013","journal-title":"J Econ Behav Organ"},{"key":"10.1016\/j.jval.2016.09.2395_bib24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/hec.2824","article-title":"Investigating attribute non\u2010attendance and its consequences in choice experiments with latent class models","volume":"22","author":"Lagarde","year":"2013","journal-title":"Health Econ"},{"key":"10.1016\/j.jval.2016.09.2395_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1037\/h0070288","article-title":"A law of comparative judgement","volume":"34","author":"Thurstone","year":"1927","journal-title":"Psychol Rev"},{"key":"10.1016\/j.jval.2016.09.2395_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00133443","article-title":"The structure of random utility models","volume":"8","author":"Manski","year":"1977","journal-title":"Theory Decis"},{"key":"10.1016\/j.jval.2016.09.2395_bib27","series-title":"Frontiers in Econometrics","first-page":"105","article-title":"Conditional logit analysis of qualitative choice behavior","author":"McFadden","year":"1973"},{"key":"10.1016\/j.jval.2016.09.2395_bib28","series-title":"Discrete Choice Methods with Simulation","author":"Train","year":"2009"},{"key":"10.1016\/j.jval.2016.09.2395_bib29","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/1099-1255(200009\/10)15:5<447::AID-JAE570>3.0.CO;2-1","article-title":"Mixed {MNL} models for discrete response","volume":"15","author":"McFadden","year":"2000","journal-title":"J Appl Econ"},{"key":"10.1016\/j.jval.2016.09.2395_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1023\/A:1022558715350","article-title":"The mixed logit model: the state of practice","volume":"30","author":"Hensher","year":"2003","journal-title":"Transportation (Amst)"},{"key":"10.1016\/j.jval.2016.09.2395_bib31","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1162\/003465398557735","article-title":"Mixed logit with repeated choices","volume":"80","author":"Revelt","year":"1998","journal-title":"Rev Econ Stat"},{"key":"10.1016\/j.jval.2016.09.2395_bib32","series-title":"BIOGEME: a free package for the estimation of discrete choice models. Presented at: The 3rd Swiss Transport Research Conference","author":"Bierlaire","year":"2003"},{"key":"10.1016\/j.jval.2016.09.2395_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jval.2016.09.2395_bib34","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1176\/ajp.2006.163.10.1697","article-title":"Medication-induced weight gain and dyslipidemia in patients with schizophrenia","volume":"163","author":"Fenton","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jval.2016.09.2395_bib35","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jval.2016.09.2395_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-244X-5-3","article-title":"Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia","volume":"5","author":"Ascher-Svanum","year":"2005","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jval.2016.09.2395_bib37","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/pds.1189","article-title":"Predictive factors of the number and the dose of anti-psychotics in a cohort of schizophrenic patients","volume":"15","author":"Lukasiewicz","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jval.2016.09.2395_bib38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00001888-200304000-00002","article-title":"Psychiatric education in an era of rapidly occurring scientific advances","volume":"78","author":"Rubin","year":"2003","journal-title":"Acad Med"},{"key":"10.1016\/j.jval.2016.09.2395_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1176\/appi.ap.34.2.115","article-title":"Training in psychiatric genomics during residency: a new challenge","volume":"34","author":"Winner","year":"2010","journal-title":"Acad Psychiatry"},{"key":"10.1016\/j.jval.2016.09.2395_bib40","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1093\/humrep\/det354","article-title":"Physician recommendation for invasive prenatal testing: the case of the \u201cprecious baby.\u201d","volume":"28","author":"Srebnik","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jval.2016.09.2395_bib41","first-page":"1715","article-title":"Comparison of vignettes, standardized patients, and chart abstraction","volume":"283","author":"Luck","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jval.2016.09.2395_bib42","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/0272989X13508007","article-title":"Validating a vignette-based instrument to study physician decision making in trauma triage","volume":"34","author":"Mohan","year":"2013","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2016.09.2395_bib43","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/09640568.2010.549367","article-title":"Non-attendance to attributes in environmental choice analysis: a latent class specification","volume":"54","author":"Campbell","year":"2011","journal-title":"J Environ Plan Manag"},{"key":"10.1016\/j.jval.2016.09.2395_bib44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10640-010-9365-6","article-title":"Dealing with ignored attributes in choice experiments on valuation of Sweden\u2019s environmental quality objectives","volume":"47","author":"Carlsson","year":"2010","journal-title":"Environ Resour Econ"},{"key":"10.1016\/j.jval.2016.09.2395_bib45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.econlet.2010.11.033","article-title":"A discrete choice model with endogenous attribute attendance","volume":"110","author":"Hole","year":"2011","journal-title":"Econ Lett"},{"key":"10.1016\/j.jval.2016.09.2395_bib46","first-page":"751","article-title":"A critical analysis of barriers to the clinical implementation of pharmacogenomics","volume":"3","author":"McKinnon","year":"2007","journal-title":"Ther Clin Risk Manag"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301516337615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301516337615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T19:34:44Z","timestamp":1692560084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301516337615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1098301516337615"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2016.09.2395","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Influence of Genotype Information on Psychiatrists\u2019 Treatment Recommendations: More Experienced Clinicians Know Better What to Ignore","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2016.09.2395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}